Dr. Michelle McMurry-Heath, Endpoints: Making Innovation Matter by Ensuring Access to Cancer Care

BIO CEO Dr. Michelle McMurry-Heath joined an Endpoints webinar sponsored by Takeda entitled ‘Making innovation matter by ensuring access to cancer care.’ Moderated by BIO Executive Committee Member Liz Lewis, Dr. McMurry-Heath’s panel included representatives from LUNGevity and Humana, with the four covering topics such as innovating and improving efficiencies in the benefit and payer systems, making sure that diversity efforts reduce disparities in access, value-based contracts, and the Accelerated Approval Pathway. Wednesday, April 6, 2022.

source